Description
INFINI XL+ LIDOCAINE PREMIUM FILLER (1x1ml) is a cross-linked hyaluronic acid dermal filler with lidocaine, dedicated to facial contouring and deep volumetric correction. With a high HA concentration of 26 mg/ml and 3% lidocaine for patient comfort, INFINI Premium Filler XL is designed to model and accentuate facial shapes in areas such as the mandibular line, bridge of the nose, chin and cheeks. The ultra-smooth gel provides visible volumetric correction through a marked increase in tissue volume, enabling precise face modelling and contouring while correcting very deep wrinkles. The product is gradually resorbable, with tissue accentuation effects described as lasting around 6–8 months and a durability rating of 5/5, corresponding to approximately 8–12 months depending on individual factors.
Bnefits
- High-concentration cross-linked hyaluronic acid (26 mg/ml) for strong volumising and contouring capability
- Contains 3% lidocaine to reduce injection pain and improve patient comfort during treatment
- Specifically dedicated to contouring and modelling facial shapes, including jawline, nose, chin and cheek volumetry
- Provides visible volumetric correction with clear enhancement of treated tissues
- Ultra-smooth, cohesive gel that distributes evenly and integrates with surrounding tissues
- Designed to correct very deep wrinkles and skin grooves in addition to volumetric contouring
- Durability rated 5/5, with effect typically lasting 8–12 months, gradually diminishing over time
- Subcutaneous injection depth provides structural support and lifting for mid- and lower-face areas
- Plasticity rating 2/5 and volume 3/5, providing a balance between structural support and mouldability
- Intended for strict medical use, offering a professional-grade solution for advanced facial contouring
Indications
- Correction and contouring of the mandibular (jaw) line
- Non-surgical modelling and correction of the bridge of the nose (nose shape)
- Chin volumetry and contouring (improving chin projection and shape)
- Cheek volumetry (increasing cheek volume and restoring mid-face fullness)
- Modelling and contouring of the overall facial shape
- Correction of very deep wrinkles and pronounced skin grooves (e.g. deep nasolabial folds or marionette lines when appropriate)
- General facial volumisation and structural support at subcutaneous depth in indicated regions
Composition
- Cross-linked hyaluronic acid 26 mg/ml (non-animal origin)
- Lidocaine 3% (for local anaesthetic effect and patient comfort)
- Physiological saline buffer with appropriate pH and osmolarity (vehicle)
- Trace amounts of cross-linking agent (e.g. BDDE) within accepted safety limits for HA fillers
Packaging
- 1 x 1 ml pre-filled glass syringe with Luer-lock connector
- Supplied with two TSK needles (25G and 27G) suitable for subcutaneous injection
- Sterile blister packaging with tamper-evident seal
- Outer carton including product labelling, batch number and expiry date
- Single-use medical device with instructions for use included in the pack
Usage
- For strict medical use only; injections must be performed by appropriately trained and qualified healthcare professionals experienced in dermal filler and facial contouring techniques.
- Before treatment, perform a full medical assessment, discuss expectations, obtain informed consent and identify indications and anatomical risk zones.
- Cleanse and disinfect all treatment areas thoroughly following aseptic protocols.
- Attach the supplied 25G or 27G TSK needle to the pre-filled syringe using the Luer-lock and carefully expel any air bubbles.
- Inject INFINI XL+ LIDOCAINE into the subcutaneous layer at the recommended depth for volumetric contouring and deep wrinkle correction, avoiding superficial intradermal placement.
- Use appropriate injection techniques (e.g. linear threading, fanning, depot/bolus injections or a combination) adapted to each anatomical region (mandibular line, nose bridge, chin, cheeks, deep folds).
- Inject slowly and carefully, aspirating where appropriate and continuously monitoring for signs of intravascular injection; avoid overcorrection in a single session.
- After injection, gently mould or massage the treated area if required to ensure even distribution and a smooth contour while respecting anatomical safety.
- Provide post-procedure care instructions: avoid makeup on treated areas for several hours; avoid extreme temperatures (sauna, sunbeds), vigorous exercise, alcohol and pressure on the treated areas for 24–48 hours, or as per clinic protocol.
- Schedule follow-up to assess results and determine whether a touch-up treatment is needed; do not re-inject the same area too soon without evaluating tissue response.
- Dispose of all used needles, syringes and any remaining product as clinical waste; do not resterilise or reuse.
Contraindications
- Known hypersensitivity or allergy to hyaluronic acid, lidocaine, other amide-type local anaesthetics or any component of the product
- History of severe allergic reactions or anaphylaxis without appropriate risk assessment and precautions
- Pregnancy or breastfeeding (as a precaution common to elective aesthetic injectable procedures)
- Patients under 18 years of age
- Active skin infections, inflammatory conditions or lesions at or near the intended injection site (e.g. herpes, bacterial or fungal infections, severe acne or dermatitis)
- Autoimmune diseases or significant immune disorders unless carefully evaluated by a specialist familiar with dermal fillers
- Bleeding disorders or significant use of anticoagulant/antiplatelet therapy unless assessed and managed by the treating physician
- Presence of permanent fillers or incompatible implants in the intended treatment area, where there may be a risk of interaction or displacement
- Injection into high-risk areas without appropriate training and anatomical knowledge (e.g. glabella, nasal region) due to the risk of vascular complications
Adverse Effects
- Common transient reactions such as redness (erythema), swelling, tenderness, pain, itching or bruising at injection sites
- Temporary palpable irregularities, nodules or asymmetry, which usually resolve spontaneously or after gentle massage or adjustment
- Local injection-site discomfort despite the presence of lidocaine, generally mild and short-lived
- Rare inflammatory or hypersensitivity reactions, including delayed-onset nodules or granulomatous responses requiring medical management
- Very rare but serious complications such as intravascular injection leading to vascular occlusion, ischaemia or tissue necrosis, particularly in high-risk facial areas
- Infection at the injection site if aseptic technique and aftercare instructions are not strictly followed
- Potential aesthetic dissatisfaction due to over- or under-correction, irregular contour or migration, which may require further corrective treatment
Storage Conditions
- Store in the original blister and outer carton to protect from light and contamination.
- Maintain at a controlled room temperature as specified on the packaging (typically between 2°C and 25°C); do not freeze.
- Do not expose to excessive heat or direct sunlight and avoid temperature extremes outside the recommended range.
- Do not use after the expiry date indicated on the packaging.
- Single-use only: once the sterile blister is opened and the syringe used, any unused product must be discarded according to local medical waste regulations.
- Keep out of the reach of children and store securely in a professional healthcare environment.
Duration
Visible volumetric and contouring effects typically last around 8\u201312 months, with tissue accentuation described as approximately 6\u20138 months and gradually weakening over time, depending on injection technique, treated area, patient age, lifestyle and individual HA metabolism.
Onset
Volumetric correction and contouring are visible immediately after injection, with final results becoming more apparent after initial swelling and redness subside over the following days.
